We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MB:NASDAQMasterBeef Group Analysis

Data as of 2026-04-16 - not real-time

$5.75

Latest Price

8/10Risk

Risk Level: High

Executive Summary

MasterBeef Group trades at $5.75, just below its 20‑day SMA of $5.83 and near the identified support level of $5.55, while the 50‑day SMA sits at $5.51, indicating a modest short‑term pullback. The RSI of 49 suggests neutral momentum, but the MACD histogram is negative and the signal line is bearish, reinforcing a cautious outlook. Volatility is extreme at 67% over the past 30 days and the beta is essentially flat, reflecting a stock that moves independently of broader market swings. Fundamentally, the company faces significant challenges: revenue is down 5.6%, operating and profit margins are negative, and the debt‑to‑equity ratio exceeds 300, dwarfing its cash reserves. However, the discounted cash‑flow model points to a fair value of $10.75, implying the current price is undervalued relative to intrinsic expectations.
The high price‑to‑book ratio of 11.3 and a historic max drawdown of 77% highlight the risk of further downside, especially given the concentration in Hong Kong’s consumer‑cyclical restaurant sector. Liquidity is thin, with daily volume averaging under 200 shares versus a 10‑day average of 9,190, elevating execution risk. Given these mixed signals, the stock sits at a crossroads between potential upside from valuation gaps and substantial fundamental and liquidity headwinds.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price hovering just above technical support
  • Bearish MACD and neutral RSI
  • Elevated short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • DCF‑derived fair value suggests upside potential
  • Persistent negative earnings and high leverage
  • Improving operating cash flow but thin liquidity

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Unsustainable debt‑to‑equity ratio
  • Continued revenue contraction in a cyclical sector
  • High geographic concentration and regulatory exposure

Key Metrics & Analysis

Financial Health

Revenue Growth-5.60%
Profit Margin-7.98%
ROE-75.28%
ROA-2.79%
Debt/Equity319.28
P/B Ratio11.3
Op. Cash Flow$44.1M
Free Cash Flow$16.2M

Technical Analysis

TrendNeutral
RSI49.1
Support$5.55
Resistance$6.50
MA 20$5.83
MA 50$5.51
MA 200$8.09
MACDBearish
VolumeIncreasing
Fear & Greed Index88.98

Valuation

Fair Value$10.75
GradeUndervalued
TypeValue

Risk Assessment

Beta-0.02
Volatility67.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.